COMMUNIQUÉS West-GlobeNewswire

BBOT Reports First Quarter 2026 Financial Results and Update on Corporate Progress
12/05/2026
Announced encouraging preliminary safety and efficacy data across all three RAS-pathway inhibitor programs Announced publication in Cancer Discovery highlighting preclinical data demonstrating BBO-11818 is a potent and [...]
Surrozen to Present at Upcoming Healthcare Investor Conference
12/05/2026
SOUTH SAN FRANCISCO, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling [...]
Neumora Therapeutics to Participate in 2026 RBC Capital Markets Global Healthcare Conference
12/05/2026
WATERTOWN, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of programs that target novel mechanisms [...]
Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates
12/05/2026
Proprietary robotically-navigated MAGiC catheter received U.S. FDA approval in January and is now being utilized at multiple sites across the United States as well as Europe Synchrony digital operating room system [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2026
12/05/2026
Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Minutes of the General Meeting of 12 May 2026
12/05/2026
Minutes of the General Meeting of 12 May 2026 Paris, 12 May 2026 – The Annual General Meeting of shareholders of Clariane (CLARI - ISIN: FR0010386334) was held on 12 May 2026 (the « General Meeting »), chaired by Sylvia [...]
UPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update
12/05/2026
CBeyond™ Expansion Study (Part C) initiated; Cohort Review Committee review scheduled for May 18, 2026, to evaluate available safety data and potential progression to Cohort 2 SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE [...]
High Diet Surpasses 1,700 Customer Reviews as Users Praise Personalized High-Protein Meal Plans
12/05/2026
1,700+ customer reviews point to High Diet's personalized high-protein meal plans and fitness tracking as the features keeping users coming back NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- High Diet has launched a [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 30 avril 2026
12/05/2026
Nombre total de droits de vote et d’actions composant le capital social au 30 avril 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
To Your Health Launches Innovative Online Protein Intake Calculator
12/05/2026
New Science-Based Tool Aims to Prevent Muscle Loss and Maintain Bone Density in Middle-Aged Women and Aging Adults Wallingford, CT, May 12, 2026 (GLOBE NEWSWIRE) -- TO YOUR HEALTH, a leader in personalized nutrition and [...]
ATUM’s New Lock-In Platform Solves Bispecific Mispairing
12/05/2026
The Platform Addresses a Key Bottleneck in Multispecific Antibody Engineering NEWARK, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- ATUM, a global leader in bioengineering and cell line development, today announced the [...]
Compte-rendu de l’Assemblée Générale du 12 Mai 2026
12/05/2026
Compte rendu de l’Assemblée générale du 12 mai 2026 Paris, le 12 mai 2026 – L’Assemblée générale annuelle des actionnaires de la société Clariane (CLARI - ISIN : FR0010386334) s’est réunie le 12 mai 2026 (l’« Assemblée [...]
RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2026 NET REVENUE +4.9%, EBITDA(1) +5.0%, ADJUSTED NET INCOME(2) +7.2%
12/05/2026
Consolidated net revenue of € 713.4 million in the first quarter of 2026, +4.9% or +8.7% on a like-for-like basis (3) at constant exchange rates (CER); adverse FX impact of € 29.1 million (-4.3%) EBITDA (1) of € 283.6 [...]
Capital Increase in Genmab as a Result of Employee Warrant Exercise
12/05/2026
Company Announcement COPENHAGEN, Denmark; May 12, 2026 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 2,346 shares as a consequence of the exercise of employee warrants. The increase is effected without [...]
Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close
12/05/2026
WARREN, N.J., May 12, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ) today announced that it has entered into a securities purchase agreement for a private investment in [...]
Rosewood STEM Magnet’s Year of National Honors Draws Recognition from McComb Orthodontics West Hollywood
12/05/2026
Ryan McComb of McComb Orthodontics West Hollywood with Friends of Rosewood STEM Elementary Board Member Katie Pisciotta, Co-President Jasmin Patterson, Board Member Ava Surkes, Co-President Anne Ramallo, Board Member [...]
Cellectis présentera des données cliniques sur lasmé-cel et éti-cel au congrès annuel de l’EHA 2026
12/05/2026
NEW YORK, 12 mai 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie de stade clinique qui utilise sa plateforme pionnière d’édition du génome pour développer des [...]
Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress
12/05/2026
Pivotal data from APEX trial in Advanced Systemic Mastocytosis accepted for oral presentation; Cogent’s third oral presentation of pivotal data with bezuclastinib at major medical meetings Preclinical data from [...]
Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress
12/05/2026
NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell [...]

Pages